View in EDS HTML Full Text PDF Full Text

MicroRNA-371-373 cluster extracellular vesicle-based communication in testicular germ cell tumors.

Saved in:
Bibliographic Details
Title: MicroRNA-371-373 cluster extracellular vesicle-based communication in testicular germ cell tumors.
Authors: Tavares NT; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / CI-IPOP@RISE Health Research Network - Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), Porto, 4200-072, Portugal.; Doctoral Programme in Biomedical Sciences, School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), Porto, 4050-313, Portugal., Lourenço C; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / CI-IPOP@RISE Health Research Network - Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), Porto, 4200-072, Portugal.; Doctoral Programme in Biomedical Sciences, School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), Porto, 4050-313, Portugal.; i3S - Instituto de Investigação e Inovação Em Saúde - University of Porto, Porto, 4200-135, Portugal.; Instituto Nacional de Engenharia Biomédica, Porto, 4200-135, Portugal., Constâncio V; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / CI-IPOP@RISE Health Research Network - Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), Porto, 4200-072, Portugal.; Doctoral Programme in Biomedical Sciences, School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), Porto, 4050-313, Portugal., Fernandes-Pontes F; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / CI-IPOP@RISE Health Research Network - Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), Porto, 4200-072, Portugal., Fonseca D; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / CI-IPOP@RISE Health Research Network - Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), Porto, 4200-072, Portugal., Silva-Santos R; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Porto, 4200-072, Portugal., Braga I; Department of Urology, Urology Clinic, Portuguese Oncology Institute of Porto (IPO Porto), Porto, 4200-072, Portugal., Maurício J; Department of Medical Oncology, Urology Clinic, Portuguese Oncology Institute of Porto (IPO Porto), Porto, 4200-072, Portugal., Henrique R; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / CI-IPOP@RISE Health Research Network - Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), Porto, 4200-072, Portugal.; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Porto, 4200-072, Portugal.; Department of Pathology and Molecular Immunology, School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), Porto, 4050-313, Portugal., Liu M; Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA., Weiss RS; Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA., Bagrodia A; Department of Urology, University of California San Diego, San Diego, CA, USA., Jerónimo C; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / CI-IPOP@RISE Health Research Network - Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), Porto, 4200-072, Portugal.; Department of Pathology and Molecular Immunology, School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), Porto, 4050-313, Portugal., Lobo J; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / CI-IPOP@RISE Health Research Network - Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), Porto, 4200-072, Portugal. joaomachadolobo@gmail.com.; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Porto, 4200-072, Portugal. joaomachadolobo@gmail.com.; Department of Pathology and Molecular Immunology, School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), Porto, 4050-313, Portugal. joaomachadolobo@gmail.com.
Source: Cell communication and signaling : CCS [Cell Commun Signal] 2025 May 30; Vol. 23 (1), pp. 252. Date of Electronic Publication: 2025 May 30.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-811X (Electronic) Linking ISSN: 1478811X NLM ISO Abbreviation: Cell Commun Signal Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1478-811X
DOI:10.1186/s12964-025-02250-8